DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20162276

A retrospective study on clinician’s practice on testing and treating for cytomegalovirus infection in patients with acute ulcerative colitis in a tertiary care center in India

Ajay Kumar, Samir Mohindra, Amar Deep, Virendra Atam, Abhijit Chandra

Abstract


Background: Reactivation of cytomegalovirus (CMV) may occur in patients with ulcerative colitis (UC) while on immunosuppressive treatment. Whereas some workers suggested that treatment of CMV is needed in them, others contradicted this. We aimed to retrospectively evaluate, a) how frequently clinicians evaluate for CMV in patients admitted with acute severe colitis, b) prevalence of its occurrence, and c) how frequently clinicians treated CMV infection in a tertiary care center.

Methods: Data on consecutive patients with UC admitted to the department of Gastroenterology during a seven-year period at a tertiary care center were retrospectively reviewed. Frequency of evaluation for CMV (IgM antibody, polymerase chain reaction or inclusion body in H and E-stained sections by the treating clinicians was evaluated. Any one test positive out of all the three tests was considered as evidence of CMV infection. Frequency of treatment directed against CMV by treating clinicians was evaluated.

Results: Among 181 admitted patients with UC, 41 (22.6%) were tested for CMV infection, of whom 28 (59.6%) were male. Fourteen of 41 (34.1%) were CMV positive (one of three above mentioned tests positive). Twelve had detectable CMV DNA by PCR and 3 had IgM antibody positive (one of whom also had inclusion body on histopathology). Three of 14 patients with CMV infection received anti-viral treatment (ganciclovir in two, ganciclovir followed by valganciclovir in one).

Conclusions: These data suggest that investigating and treating CMV as a cause for acute ulcerative colitis is becoming obsolete About one-fourth of patients admitted with severe UC in a tertiary centre are screened for CMV infection, about one-third of whom tested positive to at least one test. Only one-fifth of patients with positive result to the test were treated against the infection.

 


Keywords


Inflammatory bowel disease, Ulcerative colitis, Colectomy, Ganciclovir, Ayurvedic

Full Text:

PDF

References


Taylor GH. Cytomegalovirus. Am Fam Physician. 2003;67:519-24.

Begos DG, Rappaport R, Jain D. Cytomegalovirus infection masquerading as an ulcerative colitis flare-up: case report and review of the literature. Yale J Biol Med. 1996;69:323-8.

Dimitroulia E, Spanakis N, Konstantinidou AE, Legakis NJ, Tsakris A. Frequent detection of cytomegalovirus in the intestine of patients with inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:879-84.

Soderberg-Naucler C. Human cytomegalovirus persists in its host and attacks and avoids elimination by the immune system. Crit Rev Immunol. 2006;26:231-64.

Clark M, Colombel JF, Feagan BC, Fedorak RN, Hanauer SB, Kamm MA, et al. American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease. Gastroenterology. 2007;133:312-39.

Summers RW. Novel and future medical management of inflammatory bowel disease. Surg Clin North Am 2007;87:727-41.

Papadakis KA, Tung JK, Binder SW, Kam LY, Abreu MT, Targan SR, Vasiliauskas EA. Outcome of cytomegalovirus infections in patients with inflammatory bowel disease. Am J Gastroenterol. 2001;96:2137-42.

Matsuoka K, Iwao Y, Mori T, Sakuraba A, Yajima T, Hisamatsu T, Okamoto S, Morohoshi Y, Izumiya M, Ichikawa H, Sato T, Inoue N, Ogata H, Hibi T. Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients. Am J Gastroenterol. 2007;102:331-7.

Sood A, Midha V, Sood N, Bhatia AS, Avasthi G. Incidence and prevalence of ulcerative colitis in Punjab, North India. Gut. 2003;52:1587-90.

Kaufman HS, Kahn AC, Iacobuzio-Donahue C, Talamini MA, Lillemoe KD, Hamilton SR. Cytomegaloviral enterocolitis: clinical associations and outcome. Dis Colon Rectum. 1999;42:24-30.

Ng FH, Chau TN, Cheung TC, Kng C, Wong SY, Ng WF, et al. Cytomegalovirus colitis in individuals without apparent cause of immunodeficiency. Dig Dis Sci. 1999;44:945-52.

Kishore J, Ghoshal U, Ghoshal UC, Krishnani N, Kumar S, Singh M, Ayyagari A. Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome. J Med Microbiol. 2004;53:1155-60.

Ayre K, Warren BF, Jeffery K, Travis SP. The role of CMV in steroid-resistant ulcerative colitis: A systematic review. J Crohns Colitis. 2009;3:141-8.

Diepersloot RJ, Kroes AC, Visser W, Jiwa NM, Rothbarth PH. Acute ulcerative proctocolitis associated with primary cytomegalovirus infection. Arch Intern Med. 1990;150:1749-51.

Inoue K, Wakabayashi N, Fukumoto K, Yamada S, Bito N, Yoshida N, Katada K, Uchiyama K, Ishikawa T, Handa O, Takagi T, Konishi H, Yagi N, Kokura S, Kishimoto M, Yanagisawa A, Naito Y. Toxic megacolon associated with cytomegalovirus infection in a patient with steroid-naive ulcerative colitis. Intern Med. 2012;51:2739-43.

Lortholary O, Perronne C, Leport J, Leport C, Vilde JL. Primary cytomegalovirus infection associated with the onset of ulcerative colitis. Eur J Clin Microbiol Infect Dis. 1993;12:570-2.

Moonka D, Furth EE, MacDermott RP, Lichtenstein GR. Pouchitis associated with primary cytomegalovirus infection. Am J Gastroenterol. 1998;93:264-6.

Orvar K, Murray J, Carmen G, Conklin J. Cytomegalovirus infection associated with onset of inflammatory bowel disease. Dig Dis Sci. 1993;38:2307-10.

Osaki R, Andoh A, Tsujikawa T, Ogawa A, Koizumi Y, Nakahara T, Hata K, Sasaki M, Saito Y, Fujiyama Y. Acute cytomegalovirus infection superimposed on corticosteroid-naive ulcerative colitis. Intern Med. 2008;47:1341-4.

Pfau P, Kochman ML, Furth EE, Lichtenstein GR. Cytomegalovirus colitis complicating ulcerative colitis in the steroid-naive patient. Am J Gastroenterol. 2001;96:895-9.

Streetz KL, Buhr T, Wedemeyer H, Bleck J, Schedel I, Manns MP, Goke MN. Acute CMV-colitis in a patient with a history of ulcerative colitis. Scand J Gastroenterol 2003;38:119-22.

Hookey LC, Depew W, Boag A, Vanner S. 6-mercaptopurine and inflammatory bowel disease: hidden ground for the cytomegalovirus. Can J Gastroenterol. 2003;17:319-22.

Cottone M, Pietrosi G, Martorana G, Casa A, Pecoraro G, Oliva L, Orlando A, Rosselli M, Rizzo A, Pagliaro L. Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol. 2001;96:773-5.

Revello MG, Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev. 2002;15:680-715.

Cooper HS, Raffensperger EC, Jonas L, Fitts WT. Cytomegalovirus inclusions in patients with ulcerative colitis and toxic dilation requiring colonic resection. Gastroenterology. 1977;72:1253-6.

Eyre-Brook IA, Dundas S. Incidence and clinical significance of colonic cytomegalovirus infection in idiopathic inflammatory bowel disease requiring colectomy. Gut. 1986;27:1419-25.

Toogood GJ, Gillespie PH, Gujral S, Warren BF, Roake JA, Gray DW, Morris PJ. Cytomegalovirus infection and colonic perforation in renal transplant patients. Transpl Int. 1996;9:248-51.

Domenech E, Vega R, Ojanguren I, Hernandez A, Garcia-Planella E, Bernal I, et al. Cytomegalovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy. Inflamm Bowel Dis. 2008;14:1373-9.

Maconi G, Colombo E, Zerbi P, Sampietro GM, Fociani P, Bosani M, et al. Prevalence, detection rate and outcome of cytomegalovirus infection in ulcerative colitis patients requiring colonic resection. Dig Liver Dis. 2005;37:418-23.